| View |
|
DRP-14038-02
|
Apixaban
|
Verapix
|
2.5 mg
|
Film-Coated Tablet
|
Antithrombotic Agent (Direct factor Xa inhibitor)
|
Intas Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
24 August 2024
|
07 June 2028
|
| View |
|
DRP-14126-01
|
Glimepiride
|
None
|
2 mg
|
Film-Coated Tablet
|
Blood Glucose-Lowering Drug (Sulfonylurea)
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
04 September 2024
|
23 June 2028
|
| View |
|
DRP-14375-10
|
Dutasteride + Tamsulosin Hydrochloride
|
Durotam
|
500 mcg / 400 mcg
|
Capsule
|
Benign Prostatic Hypertrophy Drug (Alpha-adrenoreceptor antagonist)
|
Pell Tech Health Care Private Ltd.
|
India
|
CLIDP Conversion
|
08 September 2024
|
31 August 2028
|
| View |
|
DRP-11455-01
|
Ciprofloxacin Hydrochloride
|
Ciprotam
|
2 mg / mL (200 mg / 100 mL)
|
Solution for Intravenous Injection
|
Antibacterial (Fluoroquinolone)
|
Unique Pharmaceutical Laboratories (A Division of J.B. Chemicals & Pharmaceuticals Ltd.)
|
India
|
CLIDP Conversion
|
31 July 2023
|
14 March 2027
|
| View |
|
DRP-12777
|
Ibuprofen + Paracetamol
|
None
|
200mg/325mg
|
Capsule
|
Non-Steroidal Anti-Inflammatory Drug
|
Drugmaker's Laboratories, Inc.
|
Philippines
|
Renewal
|
24 October 2023
|
21 October 2028
|
| View |
|
DRP-14467-02
|
Fosfomycin (as trometamol)
|
Unifos
|
3 g per sachet
|
Powder for Oral Solution
|
Antibacterial
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
08 September 2024
|
08 September 2028
|
| View |
|
DRP-14532-05
|
Febuxostat
|
Retabustat
|
40 mg
|
Film-Coated Tablet
|
Anti-gout (Preparation Inhibiting Uric Acid Production)
|
Innova Captab Limited
|
India
|
CLIDP Conversion
|
04 September 2024
|
03 October 2028
|
| View |
|
DRP-14934-02
|
Letrozole
|
Ovalia
|
2.5 mg
|
Film-Coated Tablet
|
Antineoplastic
|
Globela Pharma Private Limited
|
India
|
CLIDP Conversion
|
08 September 2024
|
26 February 2029
|
| View |
|
DRP-14971-01
|
Amoxicillin (as trihydrate)
|
Metamox
|
500 mg
|
Capsule
|
Antibacterial
|
Reyoung Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
04 September 2024
|
28 February 2029
|
| View |
|
DRP-15067-01
|
Hydroxychloroquine Sulfate
|
Zanika
|
200 mg
|
Film- Coated Tablet
|
Antimalarial (Aminoquinolones)
|
Bafna Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
04 September 2024
|
08 April 2029
|
| View |
|
DRP-15242-01
|
Gliclazide
|
Retamicron
|
60 mg
|
Modified Release Tablet
|
Blood Glucose Lowering Drug (Sulfonylurea)
|
S Kant Healthcare Limited
|
India
|
CLIDP Conversion
|
04 September 2024
|
30 May 2029
|
| View |
|
DRP-15264-01
|
Clobetasol Propionate
|
Dermabetasol
|
0.5 mg/g (0.05% w/w)
|
Cream
|
Corticosteroid
|
PSA Chemicals & Pharmaceuticals Pvt. Ltd.
|
India
|
CLIDP Conversion
|
04 September 2024
|
04 June 2029
|
| View |
|
DRP-15295
|
Paracetamol
|
Axapara
|
10 mg / mL (1 g / 100 mL)
|
Solution for Intravenous Infusion
|
Analgesics/Antipyretic
|
AXA Parenterals Ltd
|
India
|
CLIDP Conversion
|
19 August 2024
|
03 October 2029
|
| View |
|
DRP-1589-03
|
Thiamine Mononitrate (Vitamin B1) + Pyridoxine Hydrochloride (Vitamin B6) + Cyanocobalamin (Vitamin B12)
|
None
|
100 mg/ 5 mg/ 50 mcg
|
Capsule
|
Vitamins
|
St. Martin Pharm Lab Co.
|
Philippines
|
CLIDP Conversion
|
04 September 2024
|
15 July 2028
|
| View |
|
DRP-2382-16
|
Ketorolac trometamol
|
Rotoket
|
30 mg/mL
|
Solution for Injection (IM/IV)
|
Non-Opioid Analgesic
|
Myungmoon Pharmaceutical Co., Ltd
|
Korea
|
CLIDP Conversion
|
24 August 2024
|
12 April 2025
|
| View |
|
DRP-3155-02
|
Sildenafil (as citrate)
|
Retafil
|
100 mg
|
Film-Coated Tablet
|
Urological (Drug used in Erectile Dysfunction)
|
Stallion Laboratories Pvt. Ltd
|
India
|
CLIDP Conversion
|
04 September 2024
|
11 August 2029
|
| View |
|
DRP-3220-10
|
Piperacillin (as sodium)/ Tazobactam (as sodium)
|
Dypita 2.25
|
2 g/250 mg
|
Powder for Injection (IM/IV)
|
'-'
|
Inject Care Parenterals Pvt. Ltd
|
India
|
CLIDP Conversion
|
31 August 2024
|
06 September 2029
|
| View |
|
DRP-3915-04
|
Candesartan Cilexetil
|
Retadesartz
|
8 mg
|
Tablet
|
Angiotensin II Antagonists
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
04 September 2024
|
14 August 2027
|
| View |
|
DRP-3916-04
|
Candesartan Cilexetil
|
Retadesartz
|
16 mg
|
Tablet
|
Angiotensin II Antagonist
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
04 September 2024
|
14 August 2027
|
| View |
|
DRP-4013-07
|
Carbamazepine
|
Retagral
|
200 mg
|
Tablet
|
Antiepileptic
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
08 September 2024
|
09 October 2025
|